The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: China-US Trade Talks Positive But Lower Call

Mon, 18th Nov 2019 07:42

(Alliance News) - Stock prices in London were set to open marginally lower on Monday, with investors unmoved by the latest hints US and China trade reconciliation, and amid uncertainty about US President Donald Trump's policy on auto-part imports from the European Union.

IG futures indicate the FTSE 100 index is to open 3.0 points lower at 7,300.3. The blue-chip index closed up 10.18 points, or 0.1%, on Friday at 7,302.94, ending the week down 0.8%.

"European stocks are expected to kick off a new week a little flat on Monday, with more talks between the US and China failing to excite investors in the way they have been recently," OANDA market analyst Craig Erlam said.

Top Chinese and US trade negotiators held "constructive" discussions over the phone on a preliminary trade deal between the two countries, China's commerce ministry announced in a statement on Sunday.

The long-running trade war between Washington and Beijing has weighed on the global economy and spooked markets, with the two sides imposing punitive tariffs on hundreds of billions of dollars in two-way trade.

US President Trump announced a "phase one" trade deal last month which has yet to be signed.

Vice Premier Liu He spoke with US Trade Representative Robert Lighthizer and Treasury Secretary Steven Mnuchin on Saturday, and had "constructive discussion on each side's core concerns regarding the phase-one agreement", the Chinese commerce ministry said.

The two sides will "continue to maintain close communication", it added, without providing further details.

The Japanese Nikkei 225 index closed 0.5% higher on Monday. In China, the Shanghai Composite ended up 0.6%, while the Hang Seng index in Hong Kong is up 1.3%.

In the US on Friday, stocks ended in the green, the Dow Jones Industrial Average and S&P 500 both 0.8% higher and the Nasdaq Composite up 0.7%.

Last week, a combative US president hit out at the trading bloc, labelling the European Union's barriers "very, very difficult".

According to AFP, the delay on a decision on whether to slap tariffs on auto parts imported from the European Union could last for another six months.

"Donald Trump hasn't made a decision in relation to EU auto tariffs, and that is acting as a cap to eurozone equity benchmarks. The chatter last week was the US leader would defer the decision to impose tariffs by six months. Trump might be saving the EU economic war for his campaign trail next year," CMC Markets analyst David Madden commented.

In the FTSE 100, accounting software firm Sage Group said it will secure GBP232 million from the sale of a subsidiary to global payments company Elavon.

The disposal of Sage Pay, which generated revenue of GBP41 million last year, is subject to Elavon securing approval from US regulators.

Technical products and services firm Diploma reported full-year revenue growth of 12% to GBP544.7 million.

The FTSE 250 firm's pretax profit stretched 15% year-on-year to GBP83.5 million, and Diploma upped its full-year dividend to 29.0 pence per share from 25.5p.

Looking ahead, Diploma said: "Despite the uncertain political and economic environment impacting industrial markets, the board remains confident of further progress in the current financial year as moderately lower underlying growth will be offset by a strong contribution from acquisitions."

Diploma spent GBP78.3 million, a record investment, on acquisitions in the year ended September 30.

M&A activity continued on Monday, following a busy day for the London market on Friday, which saw Amerisur Resources, Carpetright and Eddie Stobart Logistics all agreeing to purchases.

On Monday, Consort Medical was subject to a takeover bid from a subsidiary of Swedish pharmaceutical firm Recipharm AB.

Recipharm will acquire the London-listed medical devices maker for GBP505 million, paying 1,010p for each Consort share, about a 40% premium. The deal gives the company an enterprise value of GBP627 million, including debt.

In the US, the National Association of Home Builders' housing market index for November is published at 1400 GMT.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2017 08:10

Consort Medical splutters as BAT stubs out Voke programme

(ShareCast News) - British American Tobacco has terminated an agreement with Consort Medical over the manufacture of nicotine inhalers for its Voke development programme. Consort, which said it was in "constructive dialogue" with BAT's Nicovations arm and product developer Kind Consumer over the fut

Read more
6 Dec 2016 08:18

Consort Medical posts good growth in first half

(ShareCast News) - Single source drug and delivery device company Consort Medical announced its interim results for the six months to 31 October on Tuesday. The London-listed firm said group revenue increased to £144.9m from £135.5m, representing underlying growth of 2.0% and reported growth of 6.9%

Read more
25 Nov 2016 09:07

Consort Medical appoints new CFO

(ShareCast News) - Consort Medical, a global provider of manufacturing solutions for drugs, announced that it has appointed Paul Hayes as group Finance Director of the Vitec Group. Hayes is taking over the position of chief financial officer from Richard Cotton as well joining the board as executive

Read more
27 Oct 2016 07:45

Consort Medical Welcomes Cimzia Autoclicks Launch On NHS

Read more
14 Oct 2016 12:23

Consort Medical's Bespak inks new agreement

(ShareCast News) - Consort medical, a global single source drug and Delivery device company (CDMO), has announced that its Bespak division has entered into an agreement with a biopharmaceutical company. Bespak manufactures drug delivery devices for pharmaceutical partner companies including respirat

Read more
19 Sep 2016 09:07

Consort Notes European Nod For Bespak Technology-Using Product

Read more
7 Sep 2016 08:43

Consort Medical signs agreement with AstraZeneca

(ShareCast News) - Consort medical, a provider of advanced technology for drugs, has signed a new contract with pharmaceutical giant AstraZeneca for the supply of its Bespak respiratory devices. AstraZeneca and Bespak have agreed to enter into a multi-year agreement for the scale-up and supply of Be

Read more
7 Sep 2016 07:03

Consort Medical Sees Little Brexit Impact; Signs Deal With AstraZeneca

Read more
23 Jun 2016 15:19

Director dealings: Derwent London CEO sells just ahead of Brexit vote

(ShareCast News) - Derwent London chief executive John Burns has sold £1.5m of the FTSE 250 real estate investor's shares in the week just before the EU referendum which could seriously lift or undermine the company's shares. In Wednesday's sale, which comes two days before results for Britain's ref

Read more
17 Jun 2016 09:29

Numis places Consort Medical 'under review'

(ShareCast News) - Consort Medical's shares were put 'under review' by Numis after the company reported its full year results. The pharmaceutical device frim on Thursday reported full year earnings before interest and tax rose 47.6% to £37m as revenues gained 49.8% to £276.9m, driven by a strong per

Read more
16 Jun 2016 14:52

Consort Medical's annual revenues rise as a product launch is delayed

(ShareCast News) - Consort Medical, a pharmaceutical device company, revealed higher full year profits on Thursday due to organic growth and an acquisition. Revenues rose 49.8% to £276.9m from £184.8m the previous financial year. Bespak, the company's drug device manufacturing subsidiary, continued

Read more
16 Jun 2016 07:37

Consort Medical Profit Doubles As Progress Made On DEV610 Programme

Read more
9 Jun 2016 15:04

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
5 Apr 2016 08:32

BROKER RATINGS SUMMARY: Liberum Upgrades Babcock To Hold From Sell

Read more
22 Feb 2016 16:51

Consort Medical agrees partnership and invests in Precision Ocular

(ShareCast News) - Consort Medical has made a £3.3m equity investment for a 13.7% stake in retinal therapeutics specialist Precision Ocular and agreed a development and manufacturing partnership. London-based Precision Ocular has developed retinal treatments that are designed to access specific sma

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.